When blood has gone bad, patients turn normally to donors for help. But using undefined stem cells from other parts of the patient's body may help donors become more of a last-minute option in the future.

Folks living with two types of blood cancer have new choices as of today. The US Food and Drug Administration has approved Iclusig ( ponatinib ) to treat chronic myeloid leukemia ( CML ) and Philadelphia chromosome-positive acute lymphoblastic leukemia ( Ph + ALL). 

Exposure to certain chemicals is thought to be a possible cause of a blood cancer called multiple myeloma. Researchers have honed in on this to see how occupation can affect risks.

A common blood cancer in children is called acute lymphoblastic leukemia. Most children are cured of the cancer. About one in five kids, though, don’t respond to treatment. A natural alternative may help these youngsters.

Remarkable progress has been made in treating childhood leukemia. Many kids who get these blood cancers will beat their disease and live normal lives. Progress is being made in treating a more aggressive and life-threatening form of pediatric leukemia.

Chronic myeloid leukemia ( CML ) is a tricky cancer because it can respond well to initial therapy, but then that drug sometimes stops working. The same thing can happen when different – second-line – drugs are used. The reason for this is that the disease tends to keep changing or mutating.

You’ve probably heard that red wine is good for you. And maybe you’ve also heard that drinking can increase your risks of specific types of cancer. A recent review puts a checkmark in the “alcohol-healthy” column.

One type of blood cancer is fairly common in children. It’s called acute lymphoblastic leukemia, or ALL for short. Most children are cured of this cancer. In adults, though, ALL is far more ferocious.

Blood cancers, including leukemia and lymphoma, are sometimes treated with bone marrow transplants. The therapy uses stem cells to replace blood cells damaged by the cancer.

A new medication for chronic myelogenous leukemia ( CML ) has been approved by the US Food and Drug Administration.